NextCure, Inc. (NXTC)
1 Item 5.02 filing since 2026-10-30 · 1 with an open seat · roles: CMO. Nasdaq. Pharmaceutical Preparations. State: MD.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 57 | 2026-10-30 | Departure | CMO | subscribers | Open | NextCure, Inc. (NXTC): CMO Dr. Udayan Guha, M.D., Ph.D. terminated without cause |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works